Skip to content

RVMD

Revolution Medicines, Inc.

NASDAQ · Healthcare · Biotechnology · US

$190.27
+0.82%
Ask drillr
0
Insider buys (3m)
79
Insider sells (3m)
-$78.4M
Net value (3m)
-1.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 28, 2026Mancini Anthony · officer: See RemarksSale2,310$187
Oct 28, 2026Mancini Anthony · officer: See RemarksM-Exempt2,310$34
Oct 1, 2026Sandler Alan B. · officer: Chief Development OfficerSale301$205
Oct 1, 2026Sandler Alan B. · officer: Chief Development OfficerSale1,000$203
Oct 1, 2026Sandler Alan B. · officer: Chief Development OfficerSale2,200$201
Oct 1, 2026Sandler Alan B. · officer: Chief Development OfficerSale1,609$202
Oct 1, 2026Sandler Alan B. · officer: Chief Development OfficerSale1,199$204
Oct 1, 2026Sandler Alan B. · officer: Chief Development OfficerM-Exempt6,000$59
Sep 29, 2026Cislini Jeff · officer: SVP & General CounselSale765$207
Sep 28, 2026Mancini Anthony · officer: See RemarksM-Exempt3,121$34
Sep 28, 2026Mancini Anthony · officer: See RemarksSale3,121$201
Sep 28, 2026Mancini Anthony · officer: See RemarksSale587$200
Sep 24, 2026ANDERSON ELIZABETH M · directorSale1,500$195
Sep 24, 2026ANDERSON ELIZABETH M · directorM-Exempt5,070$1.12
Sep 24, 2026ANDERSON ELIZABETH M · directorSale2,648$193
Sep 24, 2026ANDERSON ELIZABETH M · directorSale4,985$193
Sep 24, 2026ANDERSON ELIZABETH M · directorSale100$195
Sep 24, 2026ANDERSON ELIZABETH M · directorSale910$192
Sep 22, 2026Mancini Anthony · officer: See RemarksSale1,764$197
Sep 18, 2026GOLDSMITH MARK A · director, officer: See RemarksSale13,775$199
Sep 18, 2026Mancini Anthony · officer: See RemarksSale27$195
Sep 18, 2026Cislini Jeff · officer: SVP & General CounselSale3,314$199
Sep 18, 2026Mancini Anthony · officer: See RemarksSale1,747$199
Sep 18, 2026Kelsey Stephen Michael · officer: See RemarksSale85$195
Sep 18, 2026Sandler Alan B. · officer: Chief Development OfficerSale5$195
Sep 18, 2026Anders Jack · officer: Chief Financial OfficerSale61$195
Sep 18, 2026Sandler Alan B. · officer: Chief Development OfficerSale336$199
Sep 18, 2026GOLDSMITH MARK A · director, officer: See RemarksSale213$195
Sep 18, 2026Horn Margaret A · officer: Chief Operating OfficerSale76$195
Sep 18, 2026Horn Margaret A · officer: Chief Operating OfficerSale4,891$199
Institutional positioning

13F filings over the trailing two quarters

New 442Increased 476Reduced 311Sold out 74
FilerActionSharesFiled
BlackRock, Inc.Increased13,695,790Aug 7, 2026
FARALLON CAPITAL MANAGEMENT LLCReduced13,604,796May 15, 2026
FARALLON CAPITAL MANAGEMENT LLCReduced13,550,796Aug 14, 2026
FMR LLCIncreased12,200,422Aug 13, 2026
BAKER BROS. ADVISORS LPIncreased11,443,357Aug 14, 2026
BLACKROCK, INC.Increased11,212,706May 13, 2026
Jupiter Topco LLCNew Position10,736,145Aug 14, 2026
Darwin Global Management, Ltd.Increased10,629,822Aug 14, 2026
JANUS HENDERSON GROUP PLCReduced9,766,496May 18, 2026
BAKER BROS. ADVISORS LPIncreased9,555,357May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased9,088,661Aug 13, 2026
FMR LLCReduced8,464,314May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position8,362,284May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased8,294,855Aug 13, 2026
NEXTECH INVEST, LTD.Unchanged7,601,087May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 28, 2026